Missing the point, and you’re wrong. RC220 didnt make it obsolete, it was obsolete because the industry doesn’t want it.
IV formula was underway and planned before EMD, RAC were due to expand to 10 sites costing between $7-$15m
Stratum 1 was entirely high dose chemo.
My point still stands. RC220 coming online didn’t invalidate RAC’s strategy, the industry had no commercial interest in high dose chemotherapy and yet they were going to pursue it with up to $15m. And the very 2 people that made these decisions (DT/PL) are still here.
As T said, thank god it didn’t go ahead as it would have wasted a ton of money and probably have been a massive set back, thank god they stuffed it up eh? RC220 arriving makes a better excuse though. At least stratum 2 may have been useful.
That’s all from me
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.020(1.69%) |
Mkt cap ! $202.4M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.17 | $1.16 | $11.46K | 9.843K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3459 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 847 | 1 |
View Market Depth
| Last trade - 14.01pm 16/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |